Compare GOCO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOCO | VNRX |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 31.9M |
| IPO Year | 2020 | 2012 |
| Metric | GOCO | VNRX |
|---|---|---|
| Price | $1.57 | $0.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $5.00 | $2.50 |
| AVG Volume (30 Days) | 34.1K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.82 | 38.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $798,894,000.00 | $1,233,511.00 |
| Revenue This Year | N/A | $60.84 |
| Revenue Next Year | N/A | $404.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.74 | ★ 59.10 |
| 52 Week Low | $1.31 | $0.17 |
| 52 Week High | $16.40 | $0.94 |
| Indicator | GOCO | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 38.64 |
| Support Level | N/A | $0.17 |
| Resistance Level | $2.56 | $0.33 |
| Average True Range (ATR) | 0.13 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 37.14 | 33.37 |
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.